HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mike Ufer Selected Research

Mike Ufer Research Topics

Disease

5Hemorrhage
01/2020 - 01/2005
3Myocardial Infarction
04/2020 - 01/2020
2Obstructive Sleep Apnea
01/2022 - 11/2021
2Sleep Initiation and Maintenance Disorders (Insomnia)
08/2021 - 02/2019
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 08/2020
2Alzheimer Disease (Alzheimer's Disease)
11/2020 - 11/2018
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 01/2007
2Breast Neoplasms (Breast Cancer)
04/2012 - 07/2010
2Epilepsy (Aura)
10/2011 - 05/2009
1Apnea
01/2022
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Conjunctivitis
01/2021
1Anemia
01/2020
1Hypotension (Low Blood Pressure)
01/2020
1Nausea
01/2020
1Intracranial Vasospasm
01/2020
1Vomiting
01/2020
1Asymptomatic Diseases
11/2018
1Amyloid Plaque
11/2018
1Dementia (Dementias)
11/2018
1Human Influenza (Influenza)
11/2017
1Fragile X Syndrome (Martin Bell Syndrome)
01/2014
1Partial Epilepsies (Epilepsy, Partial)
10/2011
1Hyperalgesia
03/2011
1Neuralgia (Stump Neuralgia)
03/2011
1Folic Acid Deficiency (Folic Acid Deficiencies)
02/2010
1Ulcerative Colitis
12/2009
1Drug Resistant Epilepsy
05/2009
1Febrile Seizures (Febrile Seizure)
05/2009
1Thromboembolism
01/2005
1Drug-Related Side Effects and Adverse Reactions
03/2004
1Atrial Fibrillation
01/2004
1Thrombophlebitis
01/2004
1Pulmonary Embolism
01/2004

Drug/Important Bio-Agent (IBA)

5daridorexantIBA
01/2022 - 02/2019
5Orexin Receptor AntagonistsIBA
01/2022 - 02/2019
4Pharmaceutical PreparationsIBA
01/2021 - 05/2009
3Purinergic P2Y Receptor AntagonistsIBA
04/2020 - 01/2020
3selatogrelIBA
04/2020 - 01/2020
3Endothelin A ReceptorIBA
01/2020 - 01/2019
3clazosentanIBA
01/2020 - 01/2019
2cenerimodIBA
01/2021 - 08/2020
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2021 - 08/2020
2UmibecestatIBA
11/2020 - 11/2018
2Proteins (Proteins, Gene)FDA Link
11/2018 - 12/2009
2EnzymesIBA
04/2012 - 07/2010
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2012 - 07/2010
2Fluorouracil (Carac)FDA LinkGeneric
04/2012 - 07/2010
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2012 - 07/2010
2Anticonvulsants (Antiepileptic Drugs)IBA
10/2011 - 05/2009
2Vitamin KFDA Link
03/2010 - 01/2005
2Warfarin (Coumadin)FDA LinkGeneric
03/2010 - 02/2010
1Amyloid beta-PeptidesIBA
11/2020
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2020
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2020
1TicagrelorIBA
01/2020
1Clopidogrel (Plavix)FDA Link
01/2020
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2020
1PotassiumIBA
01/2020
1Prasugrel HydrochlorideFDA Link
01/2020
1Amyloid (Amyloid Fibrils)IBA
11/2018
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
11/2017
1siponimodIBA
11/2017
1AntigensIBA
11/2017
1Immunoglobulins (Immunoglobulin)IBA
11/2017
1VaccinesIBA
11/2017
1mavoglurantIBA
01/2014
1hydroxide ionIBA
04/2012
1AnkyrinsIBA
03/2011
1Transient Receptor Potential ChannelsIBA
03/2011
1Phenytoin (Dilantin)FDA LinkGeneric
02/2010
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
02/2010
1hydroxyphenytoinIBA
02/2010
1Folic Acid (Vitamin M)FDA LinkGeneric
02/2010
1CytokinesIBA
12/2009
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2009
1Transcription Factors (Transcription Factor)IBA
12/2009
1cytochrome P-450 CYP2C subfamilyIBA
05/2009
1Messenger RNA (mRNA)IBA
05/2009
1Cytochrome P-450 CYP2C8IBA
05/2009
1Cytochrome P-450 CYP2C9IBA
05/2009
1Cytochrome P-450 CYP2C19IBA
05/2009
1Endothelin-Converting EnzymesIBA
01/2007
1Endothelins (Endothelin)IBA
01/2007
1ThrombinFDA Link
01/2005
1AnticoagulantsIBA
01/2004
1coumarinIBA
01/2004
1Phenprocoumon (Liquamar)FDA Link
01/2004

Therapy/Procedure

3Drug Therapy (Chemotherapy)
10/2011 - 05/2009
2Therapeutics
11/2018 - 05/2009
1Intramuscular Injections
11/2017
1Off-Label Use
03/2004